Featured
-
-
Article
| Open Access
Testing a vaccine candidate against Hepatitis C virus designed by combinatorial optimization
- Iker Malaina
- , Luis Martinez
- & Carmen Alvarez-Dominguez
-
Article
| Open Access
Epidemiological and molecular characterization of HBV and HCV infections in HIV-1-infected inmate population in Italy: a 2017–2019 multicenter cross-sectional study
- Maria Teresa Maggiorella
- , L. Sernicola
- & S. Buttò
-
Article
| Open Access
Mutational spectrum of hepatitis C virus in patients with chronic hepatitis C determined by single molecule real-time sequencing
- Fumiyasu Nakamura
- , Haruhiko Takeda
- & Hiroshi Seno
-
Article
| Open Access
Compositions of gut microbiota before and shortly after hepatitis C viral eradication by direct antiviral agents
- Yao-Chun Hsu
- , Chih-Cheng Chen
- & Chun-Ying Wu
-
Article
| Open Access
Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication
- Masato Nakai
- , Yoshiya Yamamoto
- & Naoya Sakamoto
-
Article
| Open Access
Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: a 2-year registry review
- Camila A. Picchio
- , Sabela Lens
- & Jeffrey V. Lazarus
-
Article
| Open Access
Incorporation of apolipoprotein E into HBV–HCV subviral envelope particles to improve the hepatitis vaccine strategy
- Elsa Gomez-Escobar
- , Julien Burlaud-Gaillard
- & Elodie Beaumont
-
Article
| Open Access
Assessing cost-effectiveness of hepatitis C testing pathways in Georgia using the Hep C Testing Calculator
- Madeline Adee
- , Yueran Zhuo
- & Jagpreet Chhatwal
-
Article
| Open Access
Serum lipid profile in HCV patients treated with direct-acting antivirals: a systematic review and meta-analysis
- Rosanna Villani
- , Francesca Di Cosimo
- & Gaetano Serviddio
-
Article
| Open Access
Liver stiffness regression after sustained virological response by direct-acting antivirals reduces the risk of outcomes
- Juliana Piedade
- , Gustavo Pereira
- & Hugo Perazzo
-
Article
| Open Access
Modifications of liver stiffness and CXCL4, TGF-β1 and HGF are similar in HCV- and HIV/HCV-infected patients after DAAs
- Mercedes Márquez-Coello
- , Ana Arizcorreta
- & José-Antonio Girón-González
-
Article
| Open Access
A subset of liver resident natural killer cells is expanded in hepatitis C-infected patients with better liver function
- Erin H. Doyle
- , Costica Aloman
- & Andrea D. Branch
-
Article
| Open Access
Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C in China and the United States
- Ming Yang
- , Neehar D. Parikh
- & Anna S. Lok
-
Article
| Open Access
Reconstitution of T follicular helper-humoral immune axis with elimination of hepatitis C virus
- Arshi Khanam
- , Shyamasundaran Kottilil
- & Eleanor Wilson
-
Article
| Open Access
Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot study
- Ohad Etzion
- , Harel Dahari
- & Amir Shlomai
-
Article
| Open Access
Decrease of T-cells exhaustion markers programmed cell death-1 and T-cell immunoglobulin and mucin domain-containing protein 3 and plasma IL-10 levels after successful treatment of chronic hepatitis C
- Sylwia Osuch
- , Tomasz Laskus
- & Kamila Caraballo Cortés
-
Article
| Open Access
Epidemic history and baseline resistance to NS5A-specific direct acting drugs of hepatitis C virus in Spain
- Claudia Palladino
- , Ifeanyi Jude Ezeonwumelu
- & Verónica Briz
-
Article
| Open Access
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis
- Chen-Hua Liu
- , Cheng-Yuan Peng
- & Jia-Horng Kao
-
Article
| Open Access
Fully automated rapid quantification of Hepatitis C Virus RNA in human plasma and serum by integrated on-chip RT-qPCR and capillary electrophoresis
- Samuel D. H. Chan
- , Hidenori Toyoda
- & Jian-Ping Zhang
-
Article
| Open Access
Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis
- Wei-Fan Hsu
- , Chi-Yi Chen
- & Cheng-Yuan Peng
-
Article
| Open Access
Evaluation of the efficiency of dried blood spot-based measurement of hepatitis B and hepatitis C virus seromarkers
- Chikako Yamamoto
- , Shintaro Nagashima
- & Junko Tanaka
-
Article
| Open Access
An electronic alert system increases screening for hepatitis B and C and improves management of patients with haematological disorders
- Mar Riveiro-Barciela
- , Paula Gubern
- & María Buti
-
Article
| Open Access
Single-molecular real-time deep sequencing reveals the dynamics of multi-drug resistant haplotypes and structural variations in the hepatitis C virus genome
- Taiki Yamashita
- , Haruhiko Takeda
- & Akihiro Sekine
-
Article
| Open Access
Plasma FABP4 is associated with liver disease recovery during treatment-induced clearance of chronic HCV infection
- Jean-Baptiste Gorin
- , David F. G. Malone
- & Johan K. Sandberg
-
Article
| Open Access
Hepatitis C Virus Clearance with Glucose Improvement and Factors Affecting the Glucose Control in Chronic Hepatitis C Patients
- Man Yuan
- , Juan Zhou
- & Hong Tang
-
Article
| Open Access
Cost-effectiveness of transplanting lungs and kidneys from donors with potential hepatitis C exposure or infection
- Nick Scott
- , Greg Snell
- & Joseph Doyle
-
Article
| Open Access
Hepatitis C virus infection suppresses hepatitis B virus replication via the RIG-I-like helicase pathway
- Kazuhiro Murai
- , Hayato Hikita
- & Tetsuo Takehara
-
Article
| Open Access
Improved Health Outcomes from Hepatitis C Treatment Scale-Up in Spain’s Prisons: A Cost-Effectiveness Study
- Ozden O. Dalgic
- , Sumeyye Samur
- & Jagpreet Chhatwal
-
Article
| Open Access
HCV p7 as a novel vaccine-target inducing multifunctional CD4+ and CD8+ T-cells targeting liver cells expressing the viral antigen
- Jonathan Filskov
- , Peter Andersen
- & Jens Bukh
-
Article
| Open Access
Addition of Epigallocatechin Gallate 400 mg to Sofosbuvir 400 mg + Daclatisvir 60 mg With or Without Ribavirin in Treatment of Patients with Chronic Hepatitis C Improves the Safety Profile: A Pilot Study
- Gamal Shiha
- , Reham Soliman
- & Shaker A. Mousa
-
Article
| Open Access
The reduction of miR146b-5p in monocytes and T cells could contribute to the immunopathogenesis of hepatitis C virus infection
- Yasuteru Kondo
- , Takayuki Kogure
- & Yasuhito Tanaka
-
Article
| Open Access
Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
- Lorena Vigón
- , Sonia Vázquez-Morón
- & H. Esteban
-
Article
| Open Access
HCV-specific CD4+ T cells of patients with acute and chronic HCV infection display high expression of TIGIT and other co-inhibitory molecules
- Christin Ackermann
- , Maike Smits
- & Julian Schulze zur Wiesch
-
Article
| Open Access
Virus Genotype-Dependent Transcriptional Alterations in Lipid Metabolism and Inflammation Pathways in the Hepatitis C Virus-infected Liver
- W. M. H. d’Avigdor
- , M. A. Budzinska
- & N. A. Shackel
-
Article
| Open Access
HCV Phylogeography of the General Population and High-Risk Groups in Cyprus Identifies the Island as a Global Sink for and Source of Infection
- Dimitrios Paraskevis
- , Dora C. Stylianou
- & Leondios G. Kostrikis
-
Article
| Open Access
Infection with multiple hepatitis C virus genotypes detected using commercial tests should be confirmed using next generation sequencing
- Belén Fernández-Caso
- , Jose Ángel Fernández-Caballero
- & Federico García
-
Article
| Open Access
Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery
- D. Christiansen
- , L. Earnest-Silveira
- & J. Torresi
-
Article
| Open Access
Liver sinusoidal endothelial cells (LSECs) modifications in patients with chronic hepatitis C
- Andrea Baiocchini
- , Franca Del Nonno
- & Laura Falasca
-
Article
| Open Access
Establishment and Characterization of a New Cell Line Permissive for Hepatitis C Virus Infection
- Hitoshi Omura
- , Fanwei Liu
- & Shuichi Kaneko
-
Article
| Open Access
Real-world safety and efficacy of paritaprevir/ritonavir/ombitasvir plus dasabuvir ± ribavirin in patients with hepatitis C virus genotype 1 and advanced hepatic fibrosis or compensated cirrhosis: a multicenter pooled analysis
- Chun-Hsien Chen
- , Chien-Hung Chen
- & I-Shyan Sheen
-
Article
| Open Access
Impact of novel NS5A resistance-associated substitutions of hepatitis C virus detected in treatment-experienced patients
- Sayuri Nitta
- , Yasuhiro Asahina
- & Mamoru Watanabe
-
Article
| Open Access
HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study
- Maria Rosa López-Huertas
- , Claudia Palladino
- & María Luisa Gaspar
-
Article
| Open Access
The epidemiology of hepatitis C virus in Central Asia: Systematic review, meta-analyses, and meta-regression analyses
- Welathanthrige S. P. Botheju
- , Fawzi Zghyer
- & Laith J. Abu-Raddad
-
Article
| Open Access
Association of Hepatitis C and B Virus Infection with CKD and Impact of Hepatitis C Treatment on CKD
- Hui Zhang
- , Hongqin Xu
- & Junqi Niu
-
Article
| Open Access
A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms
- Rasha El Sharkawy
- , Ali Bayoumi
- & Julie R. Jonsson
-
Article
| Open Access
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program
- Vincenza Calvaruso
- , Chiara Mazzarelli
- & Antonio Craxì
-
Article
| Open Access
Fibrogenic Gene Expression in Hepatic Stellate Cells Induced by HCV and HIV Replication in a Three Cell Co-Culture Model System
- Abdellah Akil
- , Mark Endsley
- & MinKyung Yi
-
Article
| Open Access
The risks of HCV infection among Brazilian crack cocaine users: incorporating diagnostic test uncertainty
- Carolina Coutinho
- , Leonardo S. Bastos
- & Francisco I. Bastos
-
Article
| Open Access
High density Huh7.5 cell hollow fiber bioreactor culture for high-yield production of hepatitis C virus and studies of antivirals
- Anne F. Pihl
- , Anna F. Offersgaard
- & Judith M. Gottwein
Hepatitis C virus antibody seropositivity is associated with albuminuria but not peripheral artery disease in patients with type 2 diabetes